Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Plasma Cell × apixaban × Clear all

Sponsor

Conditions

Venous Thromboembolism 5 Venous Thrombosis 4 Pulmonary Embolism 4 Neoplasms 4 Thrombosis 2 Neoplasm Metastasis 2 Intracranial Thrombosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesenteric Ischemia 1 Lymphoma 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 28 Dexamethasone 27 Melphalan 21 Busulfan 21 fludarabine phosphate 20 Bortezomib 19 Lenalidomide 18 Tacrolimus 17 Whole-Body Irradiation 15 Peripheral Blood Stem Cell Transplantation 14 Mycophenolic Acid 14 Antilymphocyte Serum 14 fludarabine 12 Calcium Dobesilate 12 Thalidomide 10 Filgrastim 10 Granulocyte Colony-Stimulating Factor 9 Methotrexate 8 pomalidomide 6 Radiotherapy 6 Cyclosporine 6 Stem Cell Transplantation 5 Rituximab 5 Etoposide 5 Cord Blood Stem Cell Transplantation 5 carfilzomib 4 Surveys and Questionnaires 4 Sirolimus 4 Methylprednisolone 4 Hematopoietic Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡